Intraoperative Neuromonitoring (IONM) Market accounted 4,433.8 USD million in 2020 and is expected to reach 8886.3 USD million by 2030 growing with a CAGR of 7.2% during the forecast period. Intraoperative neuromonitoring (IONM) or electrophysiologic monitoring is used to monitor the functional integrity of brain, brain stem, spinal cord, or peripheral nerves during surgery. IONM has enormous value in medical industry in terms of patient safety. The assessment of neuronal function during surgical intervention has higher importance to avoid the damage or injury of nervous system. The prevention of permanent damage of neural structure is a vital to circumvent post-operative complications such as paralysis, muscle weakness, hearing loss or further serious complications. The change in perspective of medical technology and increase in adoption of IONM devices are assumed to substantial growth of market in future.
Market Segmentation:
:
Based on product & services, the global intraoperative neuromonitoring market is bifurcated into systems, accessories, and services. By source, the market is divided into insourced monitoring and outsourced monitoring. Depending on application, the market is categorised as spinal surgery, neurosurgery, vascular surgery, ear nose throat (ENT) surgery, and orthopaedic surgery. On basis of end user, the global market is classified into hospitals and ambulatory surgical centres. By the region, the intraoperative neuromonitoring market is segmented into North America (NA), Europe (EU), Asia Pacific (APAC), and RoW.
Market Dynamics and Factors:
An increasing prevalence of neurological disorder, rising awareness of patient safety, growing neurological centres is major driver for the growth of the global intraoperative neuromonitoring market. Moreover, growing prevalence of chronic disorders, rising volume of surgeries and increasing emphasis on patient safety during complicated surgeries are some of the other factors which will drive the market. However, the lack of awareness of this application may restrain of the market growth. Moreover, increasing medical tourism as spine surgery to products and service providers are creating immense opportunities for the market growth during forecast timeframe. Further, the increasing adoption of technological advanced procedures, healthcare expenditure for R&D to manufacture newer and innovative technologies, favourable reimbursement policies which are expected to fuel the growth of the global market during the forecast time frame. Further, the lack of appropriate skilled health professional and lack of awareness in developing countries is considered to be the challenge for intraoperative neuromonitoring market.
Geographic Analysis:
North America is considered to account for a largest share of the global intraoperative neuromonitoring market during the forecast period, owing to well-developed healthcare infrastructure, presence of major players of intraoperative neuromonitoring devices, increasing demand for neurologic care, rising patient safety in this region. Asia pacific is expected to fastest growth of the market due to huge number of population suffering from neurologic disorders, emerging medical tourism and developing healthcare infrastructure. Additionally, Europe is expected to account for a significant share of the market during the forecast period due to well-established health care infrastructure and rising awareness about patient safety during surgery in this region.
Competitive Scenario:
The key players of global intraoperative neuromonitoring markets are Medtronic plc. Computational Diagnostics, Inc., Cadwell Industries, NuVasive, Inc., Inomed Medizintechnik GmbH, Accurate Monitoring LLC, Nihon Kohden Corporation, Moberg Research, Inc., Natus Medical, and SpecialtyCare.
Intraoperative Neuromonitoring Market Report Scope
| Report Attribute | Details |
| Analysis Period | 2020–2030 |
| Base Year | 2021 |
| Forecast Period | 2022–2030 |
| Market Size Estimation | Million (USD) |
| Growth Rate (CAGR%) | 7.2 % |
|
| By Product (Systems, Accessories, and Services), By Source Type (Insourced Monitoring and Outsourced Monitoring), By Application (Spinal Surgery, Neurosurgery, Vascular Surgery, Ear Nose Throat (ENT) Surgery, and Orthopaedic Surgery), By End User (Hospitals and Ambulatory Surgical Centres) |
| Geographical Segmentation | North America (U.S., Canada, Mexico) Europe (UK, Germany, Italy, France, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), South America (Brazil, Argentina, Rest of SA), MEA (UAE, Saudi Arabia, South Africa) |
| Key Companies Profiled | Medtronic plc. Computational Diagnostics, Inc., Cadwell Industries, NuVasive, Inc., Inomed Medizintechnik GmbH, Accurate Monitoring LLC, Nihon Kohden Corporation, Moberg Research, Inc., Natus Medical, and SpecialtyCare. |
